Ebola situation in Congo

 This is just copied from Google

As of November 13, 2026, the Ebola outbreak in the Democratic Republic of the Congo (DRC) has surpassed 11,000 confirmed cases and 5,000 deaths since it began in May, making it the country's largest outbreak on record. According to UN News, the crisis is being severely hampered by armed conflict and an escalating hunger emergency. [1]

Epidemiological Status & Viral Strain

Scale and Spread. While prevention efforts have reduced transmission in some initial hotspots, up to 500 new infections are still being diagnosed each week as the virus moves into more remote, hard-to-reach rural areas. The outbreak began in northeastern Ituri province and has spread across seven other provinces, with most cases concentrated in Ituri and North Kivu. [1, 2, 3]
Rare Virus Strain. According to the World Health Organization (WHO), the outbreak is driven by the Bundibugyo virus, a rare species of Ebola for which there are currently no licensed vaccines or approved specific therapeutics. Clinical trials are underway to test whether Ervebo (a vaccine approved for the Zaire strain) offers cross-protection. [1, 2, 3]
Global Emergency. The WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC) in mid-May 2026. Cross-border cases have also been reported in Uganda, Kenya, and Nigeria. [1, 2, 3, 4]

Security Obstacles & Attacks on Health Workers

Armed Group Violence. UN Senior Ebola Response Coordinator Julien Harneis warned on November 13 that attacks by armed groups—specifically the Allied Democratic Forces (ADF)—are killing more people in recent days across southern Ituri and North Kivu than the virus itself. [1]
Targeted Facilities. Since May, the WHO has logged roughly 80 attacks on healthcare facilities and workers. Recent violence in North Kivu killed 66 civilians (including three health workers) and resulted in three facilities being looted and burned, forcing Ebola patients and roughly 1,000 tracked contacts to flee. [1, 2]
Response Disruption. UN officials note that conducting contact tracing in areas where armed militias operate has become extremely hazardous, frequently forcing temporary suspensions of local medical operations. [1, 2]

Compounding Humanitarian Crisis

Acute Food Insecurity. The UN World Food Programme (WFP) warns that nearly 29 million people across the DRC face acute food insecurity, with the worst conditions concentrated in the conflict- and Ebola-affected eastern and northeastern provinces.
Impact on Children. According to UNICEF, the outbreak has shuttered schools and clinics, disrupted routine childhood immunizations, and heightened protection risks for displaced children. UN agencies continue to emphasize grassroots community engagement and the training of local health workers to combat misinformation and encourage early isolation. [1, 2]

If you would like to explore further, I can pull the latest WHO regional breakdown by province or look into the clinical trials underway for the Bundibugyo strain. Which would be most useful?

clinical trials

Because there are currently no licensed vaccines or approved treatments specifically for the Bundibugyo strain, the World Health Organization (WHO) and national partners have launched adaptive clinical trials in the DRC to test both experimental vaccines and therapeutics. [1, 2]

Vaccine Trials: The Tumaini Study

Launched on October 23, 2026, in Bunia (Ituri province) and led by the DRC’s National Institute for Biomedical Research (INRB) alongside WHO and Doctors Without Borders (MSF), the Phase 2/3 Tumaini trial (meaning "hope" in Swahili) uses a ring-vaccination strategy to immunize high-risk groups and contacts of confirmed patients: [1, 2, 3]

• Ervebo (Cross-Protection Evaluation). Already deployed in active vaccination rings, this vaccine—originally licensed for the Zaire Ebola strain—is being evaluated to see if it offers cross-protection against Bundibugyo. Unlike many past trials, it includes pregnant women and children down to one year of age. [1, 2, 3]
• ChAdOx1-BDBV. Developed by the University of Oxford with the Serum Institute of India, this viral-vector vaccine is specifically engineered to target the Bundibugyo virus. Following Phase 1 safety trials in the UK and Uganda, a WHO expert group recommended on November 4 that it join the Tumaini trial pending final national sign-off. [1, 2, 3, 4]
• mRNA-1469. Developed by Moderna, this mRNA vaccine candidate specifically targets Bundibugyo and was also recommended by the WHO on November 4 to enter the Tumaini trial alongside ChAdOx1. [1]

Initial efficacy results from the Tumaini vaccine trial are expected in early 2027. [1, 2]

WHO Director-General Dr. Tedros Adhanom Ghebreyesus explains the decision to add these two Bundibugyo-specific vaccine candidates to the DRC trial:

Treatment & Prophylaxis Trials: PARTNERS & Post-Exposure

Alongside vaccine testing, the WHO is sponsoring therapeutic studies to improve survival rates for infected patients and protect exposed individuals: [1]

• The PARTNERS Trial. Launched in July 2026, this clinical study is testing whether the monoclonal antibody MBP134, the antiviral drug remdesivir, or a combination of both reduces mortality in patients with confirmed Bundibugyo virus disease. [1]
• Maftivimab Addition. The WHO announced in early November that maftivimab, another monoclonal antibody candidate, will soon be added as an evaluation arm to the PARTNERS treatment trial. [1, 2]
• Obeldevisir Prophylaxis. A complementary study is underway evaluating the oral antiviral obeldevisir as a post-exposure prophylaxis to prevent the disease from developing in people recently exposed to the virus. [1, 2]

Initial findings from these treatment trials are anticipated over the coming months. [1]

Would you like to look closer at how ring vaccination is being carried out amid the security challenges in Ituri and North Kivu, or explore the early-stage science behind why Zaire-strain treatments differ from Bundibugyo?

I have a friend in Uvira.  I'm worried about him.

It is completely understandable to be worried right now. While South Kivu province (where Uvira is located) is not the main epicenter of the Ebola outbreak, the city is facing heightened tension from both regional health risks and escalating conflict. [1, 2, 3]

1. Ebola Risk in Uvira and South Kivu

• Not the Primary Epicenter. Nearly all active Ebola cases are concentrated hundreds of miles north in Ituri (nearly 70% of all cases) and North Kivu. While South Kivu is listed among the eight provinces that have recorded at least one case since May, daily situation reports from mid-November show no major active transmission clusters in the Uvira area. [1, 2]
• Transit Hub Vulnerability. Because Uvira sits on the northern shore of Lake Tanganyika right across from Burundi, it is a busy commercial and transit port. Health agencies maintain screening checkpoints along major travel corridors to catch travel-related cases early. [1, 2]

2. Security & Humanitarian Situation in Uvira

• Rebel Pressure and Conflict. The more immediate concern in South Kivu right now is armed conflict. Following the October formation of a new rebel coalition (the FRN, merging M23 and the Congo River Alliance), fighting has surged across five of South Kivu's eight territories. Field reports from November indicate rebel forces have been actively pressuring areas around Uvira, prompting large peace demonstrations in the city led by the provincial governor. [1, 2]
• Strain on Local Resources. Across South Kivu, fighting has displaced hundreds of thousands of people and disrupted food supply chains, leading UN agencies to warn of severe food insecurity and strained local clinics. [1, 2]

Practical Ways to Check In & Support Your Friend

• Ask about local movement and safety. When you reach out, check whether basic services, markets, and roads around his neighborhood are operating normally, and whether he has a safe place to stay if tensions flare.
• Share basic prevention reminders gently. Ebola spreads only through direct physical contact with the bodily fluids of someone who is sick or has recently died from the virus—not through the air. Remind him to practice frequent handwashing, avoid crowded clinics unless necessary, and steer clear of anyone showing symptoms like sudden fever, severe weakness, or vomiting.
• Keep communication lines flexible. Power outages or mobile network disruptions can happen during periods of unrest. Agreeing on a backup way to check in (like SMS text messages, which often go through when mobile data is down) can give you both peace of mind. [1, 2]

Would you like to set up a task to alert you if there are any major security developments or new Ebola cases reported in Uvira and South Kivu?